R&D Applying genetics to chemistry to find new small molecules For all the advances that have been made in it, drug discovery is still a hit or miss process, as much an art as a science.
R&D JP Morgan 2024 – Sam Deutsch In another lightning round JP Morgan interview, editor-in-chief Jonah Comstock caught up with Sam Deutsch, CEO of Nutcracker Therapeutics, to talk briefly about the company’s lead asset for cervica
R&D Clinical research is about trial and error Companies have been trying to expedite and optimise drug trials for ages.
R&D Sponsored Patentability and predictability in AI-assisted drug discove... Artificial intelligence (AI) and machine learning (ML) are ushering in a new era in drug discovery.
R&D Transforming clinical data management systems for biotechnol... In the dynamic environment of biotechnology trials, the significance of Clinical Data Management systems (CDMs) cannot be overstated.
R&D JP Morgan 2024 – Xavier Duportet There were plenty of gene therapy companies around at JP Morgan 2024, and more than a few companies focused on the microbiome.
News Astellas pays $285m for Audax cancer drug, and other deals Astellas takes an option on a cancer immunotherapy developed by Audax for up to $1.34bn, with Gilead and Teva also adding to their pipelines.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
